Immuneering (IMRX) Other Non-Current Assets (2020 - 2024)
Historic Other Non-Current Assets for Immuneering (IMRX) over the last 5 years, with Q3 2024 value amounting to $1.3 million.
- Immuneering's Other Non-Current Assets rose 7423.38% to $1.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.3 million, marking a year-over-year increase of 7423.38%. This contributed to the annual value of $1.0 million for FY2023, which is 3909.4% up from last year.
- Immuneering's Other Non-Current Assets amounted to $1.3 million in Q3 2024, which was up 7423.38% from $1.2 million recorded in Q2 2024.
- Immuneering's 5-year Other Non-Current Assets high stood at $1.3 million for Q3 2024, and its period low was $14333.0 during Q4 2020.
- For the 5-year period, Immuneering's Other Non-Current Assets averaged around $650662.8, with its median value being $743703.0 (2022).
- Within the past 5 years, the most significant YoY rise in Immuneering's Other Non-Current Assets was 504402.43% (2022), while the steepest drop was 9067.26% (2022).
- Over the past 5 years, Immuneering's Other Non-Current Assets (Quarter) stood at $14333.0 in 2020, then soared by 612.54% to $102129.0 in 2021, then skyrocketed by 628.2% to $743703.0 in 2022, then soared by 39.09% to $1.0 million in 2023, then increased by 25.26% to $1.3 million in 2024.
- Its last three reported values are $1.3 million in Q3 2024, $1.2 million for Q2 2024, and $1.2 million during Q1 2024.